Methods of lowering active TNF-.alpha. levels in mammals using tumor necrosis factor receptor
US5605690A · kind A · utility
297Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 1995 |
| Grant date | Feb 25, 1997 |
| Priority date | — |
| Expiry date | Feb 8, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/868
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating TNF-dependent inflammatory diseases in a mammal by administering a TNF antagonist, such as soluble TNFR.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.